O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee

Elizabeth A Sadowski, Isabelle Thomassin-Naggara, Andrea Rockall, Katherine E Maturen, Rosemarie Forstner, Priyanka Jha, Stephanie Nougaret, Evan S Siegelman, Caroline Reinhold, Elizabeth A Sadowski, Isabelle Thomassin-Naggara, Andrea Rockall, Katherine E Maturen, Rosemarie Forstner, Priyanka Jha, Stephanie Nougaret, Evan S Siegelman, Caroline Reinhold

Abstract

MRI plays an important role as a secondary test or problem-solving modality in the evaluation of adnexal lesions depicted at US. MRI has increased specificity compared with US, decreasing the number of false-positive diagnoses for malignancy and thereby avoiding unnecessary or over-extensive surgery in patients with benign lesions or borderline tumors, while women with possible malignancies can be expeditiously referred for oncologic surgical evaluation. The Ovarian-Adnexal Reporting and Data System (O-RADS) MRI Committee is an international collaborative effort formed under the direction of the American College of Radiology and includes a diverse group of experts on adnexal imaging and management who developed the O-RADS MRI risk stratification system. This scoring system assigns a probability of malignancy based on the MRI features of an adnexal lesion and provides information to facilitate optimal patient management. The widespread implementation of a codified reporting system will lead to improved interpretation agreement and standardized communication between radiologists and referring physicians. In addition, it will allow for high-quality multi-institutional collaborations-an important unmet need that has hampered the performance of high-quality research in this area in the past. This article provides guidelines on using the O-RADS MRI risk stratification system in clinical practice, as well as in the educational and research settings.

Conflict of interest statement

Disclosures of Conflicts of Interest: E.A.S. No relevant relationships. I.T.N. Payment from CFIM education learning; payment for lectures including service on speakers bureaus from GE, Hologic, Canon, Guerbet, and Siemens; payment for development of educational presentations from CFIM and ESOR; travel/accommodations/meeting expenses unrelated to activities listed from GE. A.R. NIHR grants to institution; travel/accommodations/meeting expenses unrelated to activities listed from Guerbet/European Society of Radiology. K.E.M. No relevant relationships. R.F. Payment for lectures including service on speakers bureaus from ESUR/European Society of Radiology. P.J. Expert testimony from MCIC Vermont; payment for lectures including service on speakers bureaus from Society of Radiologists in Ultrasound. S.N. No relevant relationships. E.S.S. Consultant for Covera Health, Icon Medical Imaging, Bioclinica, and Invicros. C.R. No relevant relationships.

© RSNA, 2022 See also the editorial by Levine in this issue.

Figures

Graphical abstract
Graphical abstract
Figure 1:
Figure 1:
Image shows Ovarian-Adnexal Reporting and Data System (O-RADS) MRI risk stratification system. DCE = dynamic contrast enhanced, DWI = diffusion-weighted imaging, N/A = not applicable, PPV = positive predictive value. Reprinted, with permission, from the American College of Radiology.
Figure 2:
Figure 2:
Graph depicts the visual differences between low-risk, intermediate-risk, and high-risk time-intensity curves (TICs). A low-risk TIC is defined as an increase in the signal intensity of solid tissue after contrast material administration, slower than that in the myometrium, without a well-defined shoulder and no plateau. An intermediate-risk TIC has a moderate initial rise in the signal intensity of solid tissue, with a slope slower than or equal to that of the myometrium, with a shoulder and plateau. A high-risk TIC has a brisk initial rise in the signal intensity of solid tissue, with a slope greater than myometrium, with a shoulder and plateau.
Figure 3:
Figure 3:
Image shows examples of Ovarian-Adnexal Reporting and Data System (O-RADS) MRI 1 risk score. * = In postmenopausal women, normal ovaries can contain very small residual follicles, and if the radiologist subjectively assesses the ovaries as normal, the ovaries can be categorized as O-RADS MRI 1. DWI = diffusion-weighted imaging, FS = fat saturated, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging.
Figure 4:
Figure 4:
Image shows examples of Ovarian-Adnexal Reporting and Data System (O-RADS) MRI 2 risk score. ^ = Unilocular cysts with simple or hemorrhagic fluid 3 cm or smaller in a premenopausal woman would be classified as O-RADS MRI 1. ^^ = Minimal enhancement of Rokitansky nodule in lesion containing lipid does not change to O-RADS MRI 4. DWI = diffusion-weighted imaging, FS = fat saturated, PPV = positive predictive value, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging.
Figure 5:
Figure 5:
Image shows examples of Ovarian-Adnexal Reporting and Data System (O-RADS) MRI 3 risk score. ^^ = Hemorrhagic cyst smaller than 3 cm in a premenopausal woman would be classified as O-RADS MRI 2. DCE = dynamic contrast enhanced, DWI = diffusion-weighted imaging, FS = fat saturated, PPV = positive predictive value, TIC = time-intensity curve, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging.
Figure 6:
Figure 6:
Image shows examples of Ovarian-Adnexal Reporting and Data System (O-RADS) MRI 4 risk score. DCE = dynamic contrast enhanced, DWI = diffusion-weighted imaging, FS = fat saturated, PPV = positive predictive value, TIC = time-intensity curve, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging.
Figure 7:
Figure 7:
Image shows examples of Ovarian-Adnexal Reporting and Data System (O-RADS) MRI 5 risk score. DCE = dynamic contrast enhanced, DWI = diffusion-weighted imaging, FS = fat saturated, PPV = positive predictive value, TIC = time-intensity curve, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging.

References

    1. Andreotti RF , Timmerman D , Strachowski LM , et al. . O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee . Radiology 2020. ; 294 ( 1 ): 168 – 185 .
    1. Levine D , Brown DL , Andreotti RF , et al. . Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement . Ultrasound Q 2010. ; 26 ( 3 ): 121 – 131 .
    1. Timmerman D , Van Calster B , Testa A , et al. . Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group . Am J Obstet Gynecol 2016. ; 214 ( 4 ): 424 – 437 .
    1. Timmerman D , Ameye L , Fischerova D , et al. . Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group . BMJ 2010. ; 341 c6839 .
    1. Sadowski EA , Paroder V , Patel-Lippmann K , et al. . Indeterminate Adnexal Cysts at US: Prevalence and Characteristics of Ovarian Cancer . Radiology 2018. ; 287 ( 3 ): 1041 – 1049 .
    1. Zhang X , Mao Y , Zheng R , et al. . The contribution of qualitative CEUS to the determination of malignancy in adnexal masses, indeterminate on conventional US - a multicenter study . PLoS One 2014. ; 9 ( 4 ): e93843 .
    1. Patel-Lippmann KK , Sadowski EA , Robbins JB , et al. . Comparison of International Ovarian Tumor Analysis Simple Rules to Society of Radiologists in Ultrasound Guidelines for Detection of Malignancy in Adnexal Cysts . AJR Am J Roentgenol 2020. ; 214 ( 3 ): 694 – 700 .
    1. Thomassin-Naggara I , Poncelet E , Jalaguier-Coudray A , et al. . Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses . JAMA Netw Open 2020. ; 3 ( 1 ): e1919896 .
    1. Hricak H , Chen M , Coakley FV , et al. . Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis . Radiology 2000. ; 214 ( 1 ): 39 – 46 .
    1. Kaijser J , Vandecaveye V , Deroose CM , et al. . Imaging techniques for the pre-surgical diagnosis of adnexal tumours . Best Pract Res Clin Obstet Gynaecol 2014. ; 28 ( 5 ): 683 – 695 .
    1. Kinkel K , Lu Y , Mehdizade A , Pelte MF , Hricak H . Indeterminate ovarian mass at US: incremental value of second imaging test for characterization—meta-analysis and Bayesian analysis . Radiology 2005. ; 236 ( 1 ): 85 – 94 .
    1. Nunes N , Ambler G , Foo X , Naftalin J , Widschwendter M , Jurkovic D . Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis . Ultrasound Obstet Gynecol 2014. ; 44 ( 5 ): 503 – 514 .
    1. Forstner R , Thomassin-Naggara I , Cunha TM , et al. . ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update . Eur Radiol 2017. ; 27 ( 6 ): 2248 – 2257 . [Published correction appears in Eur Radiol 2017;27(6):2258.]
    1. Maturen KE , Blaty AD , Wasnik AP , et al. . Risk Stratification of Adnexal Cysts and Cystic Masses: Clinical Performance of Society of Radiologists in Ultrasound Guidelines . Radiology 2017. ; 285 ( 2 ): 650 – 659 .
    1. Nunes N , Ambler G , Foo X , Widschwendter M , Jurkovic D . Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting . Ultrasound Obstet Gynecol 2018. ; 51 ( 6 ): 829 – 835 .
    1. Pereira PN , Sarian LO , Yoshida A , et al. . Improving the performance of IOTA simple rules: sonographic assessment of adnexal masses with resource-effective use of a magnetic resonance scoring (ADNEX MR scoring system) . Abdom Radiol (NY) 2020. ; 45 ( 10 ): 3218 – 3229 .
    1. Bernardin L , Dilks P , Liyanage S , Miquel ME , Sahdev A , Rockall A . Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation . Eur Radiol 2012. ; 22 ( 4 ): 880 – 890 .
    1. Dilks P , Narayanan P , Reznek R , Sahdev A , Rockall A . Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass? Eur Radiol 2010. ; 20 ( 9 ): 2176 – 2183 .
    1. Iyer VR , Lee SI . MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization . AJR Am J Roentgenol 2010. ; 194 ( 2 ): 311 – 321 .
    1. Komatsu T , Konishi I , Mandai M , et al. . Adnexal masses: transvaginal US and gadolinium-enhanced MR imaging assessment of intratumoral structure . Radiology 1996. ; 198 ( 1 ): 109 – 115 .
    1. Sadowski EA , Robbins JB , Rockall AG , Thomassin-Naggara I . A systematic approach to adnexal masses discovered on ultrasound: the ADNEx MR scoring system . Abdom Radiol (NY) 2018. ; 43 ( 3 ): 679 – 695 .
    1. Siegelman ES , Outwater EK . Tissue characterization in the female pelvis by means of MR imaging . Radiology 1999. ; 212 ( 1 ): 5 – 18 .
    1. Sohaib SA , Sahdev A , Van Trappen P , Jacobs IJ , Reznek RH . Characterization of adnexal mass lesions on MR imaging . AJR Am J Roentgenol 2003. ; 180 ( 5 ): 1297 – 1304 .
    1. Vargas HA , Barrett T , Sala E . MRI of ovarian masses . J Magn Reson Imaging 2013. ; 37 ( 2 ): 265 – 281 .
    1. Mohaghegh P , Rockall AG . Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques . RadioGraphics 2012. ; 32 ( 6 ): 1751 – 1773 .
    1. Thomassin-Naggara I , Balvay D , Aubert E , et al. . Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study . Eur Radiol 2012. ; 22 ( 4 ): 738 – 745 .
    1. Thomassin-Naggara I , Toussaint I , Perrot N , et al. . Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging . Radiology 2011. ; 258 ( 3 ): 793 – 803 .
    1. Thomassin-Naggara I , Aubert E , Rockall A , et al. . Adnexal masses: development and preliminary validation of an MR imaging scoring system . Radiology 2013. ; 267 ( 2 ): 432 – 443 .
    1. Adusumilli S , Hussain HK , Caoili EM , et al. . MRI of sonographically indeterminate adnexal masses . AJR Am J Roentgenol 2006. ; 187 ( 3 ): 732 – 740 .
    1. Anthoulakis C , Nikoloudis N . Pelvic MRI as the “gold standard” in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review . Gynecol Oncol 2014. ; 132 ( 3 ): 661 – 668 .
    1. Sohaib SA , Mills TD , Sahdev A , et al. . The role of magnetic resonance imaging and ultrasound in patients with adnexal masses . Clin Radiol 2005. ; 60 ( 3 ): 340 – 348 .
    1. Spencer JA , Ghattamaneni S . MR imaging of the sonographically indeterminate adnexal mass . Radiology 2010. ; 256 ( 3 ): 677 – 694 .
    1. Morice P , Denschlag D , Rodolakis A , et al. . Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors . Int J Gynecol Cancer 2011. ; 21 ( 5 ): 951 – 963 .
    1. McEvoy SH , Nougaret S , Abu-Rustum NR , et al. . Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management . Abdom Radiol (NY) 2017. ; 42 ( 10 ): 2488 – 2512 . [Published correction appears in Abdom Radiol (NY) 2017;42(12):2966-2973.]
    1. Rockall AG , Qureshi M , Papadopoulou I , et al. . Role of Imaging in Fertility-sparing Treatment of Gynecologic Malignancies . RadioGraphics 2016. ; 36 ( 7 ): 2214 – 2233 .
    1. Stein EB , Hansen JM , Maturen KE . Fertility-Sparing Approaches in Gynecologic Oncology: Role of Imaging in Treatment Planning . Radiol Clin North Am 2020. ; 58 ( 2 ): 401 – 412 .
    1. ACR-O-RADS-MRI-Lexicon . . Accessed November 3, 2020 .
    1. O-RADS-MR-Risk-Stratification-System-Table . . Accessed October 16, 2020 .
    1. Reinhold C , Rockall A , Sadowski EA , et al. . Ovarian-Adnexal Reporting Lexicon for MRI: A White Paper of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Committee . J Am Coll Radiol 2021. ; 18 ( 5 ): 713 – 729 .
    1. Basha MAA , Abdelrahman HM , Metwally MI , et al. . Validity and Reproducibility of the ADNEX MR Scoring System in the Diagnosis of Sonographically Indeterminate Adnexal Masses . J Magn Reson Imaging 2021. ; 53 ( 1 ): 292 – 304 .
    1. Pereira PN , Sarian LO , Yoshida A , et al. . Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses . Diagn Interv Radiol 2018. ; 24 ( 2 ): 63 – 71 .
    1. Ruiz M , Labauge P , Louboutin A , Limot O , Fauconnier A , Huchon C . External validation of the MR imaging scoring system for the management of adnexal masses . Eur J Obstet Gynecol Reprod Biol 2016. ; 205 ( 115 ): 119 .
    1. Sasaguri K , Yamaguchi K , Nakazono T , et al. . External validation of ADNEX MR SCORING system: a single-centre retrospective study . Clin Radiol 2019. ; 74 ( 2 ): 131 – 139 .
    1. Hauptmann S , Friedrich K , Redline R , Avril S . Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria . Virchows Arch 2017. ; 470 ( 2 ): 125 – 142 .
    1. Maizlin ZV , Shewchuk JR , Clement JJ . Easy ways to remember the progression of MRI signal intensity changes of intracranial hemorrhage . Can Assoc Radiol J 2009. ; 60 ( 2 ): 88 – 90 .
    1. Parizel PM , Makkat S , Van Miert E , Van Goethem JW , van den Hauwe L , De Schepper AM . Intracranial hemorrhage: principles of CT and MRI interpretation . Eur Radiol 2001. ; 11 ( 9 ): 1770 – 1783 .
    1. Zhou H , Ma X , Sheng M , Lai C , Fu J . Evolution of intramural duodenal hematomas on magnetic resonance imaging . Pediatr Radiol 2018. ; 48 ( 11 ): 1593 – 1599 .
    1. Corwin MT , Gerscovich EO , Lamba R , Wilson M , McGahan JP . Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign . Radiology 2014. ; 271 ( 1 ): 126 – 132 .
    1. Togashi K , Nishimura K , Kimura I , et al. . Endometrial cysts: diagnosis with MR imaging . Radiology 1991. ; 180 ( 1 ): 73 – 78 .
    1. Chiang AJ , Chen MY , Weng CS , et al. . Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study . J Gynecol Oncol 2017. ; 28 ( 5 ): e69 .
    1. Duffy S , Day EK , Bryson G , Millan D , Lindsay R . Malignant tumours arising within mature cystic teratomas of the ovary: Prevalence and clinical outcomes . Eur J Obstet Gynecol Reprod Biol 2018. ; 221 ( 198 ): 199 .
    1. Kido A , Togashi K , Konishi I , et al. . Dermoid cysts of the ovary with malignant transformation: MR appearance . AJR Am J Roentgenol 1999. ; 172 ( 2 ): 445 – 449 .
    1. Menon U , Karpinskyj C , Gentry-Maharaj A . Ovarian Cancer Prevention and Screening . Obstet Gynecol 2018. ; 131 ( 5 ): 909 – 927 .
    1. Trimbos JB . Surgical treatment of early-stage ovarian cancer . Best Pract Res Clin Obstet Gynaecol 2017. ; 41 ( 60 ): 70 .
    1. O-RADS MRI Calculator for Adnexal Lesions . . Accessed March 16, 2021 .

Source: PubMed

3
Abonneren